Global Neuroprosthetics Market to Reach $22.5 Billion by 2030
The global market for Neuroprosthetics estimated at US$9 Billion in the year 2022, is projected to reach a revised size of US$22.5 Billion by 2030, growing at a CAGR of 12.1% over the analysis period 2022-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is projected to record a 13.3% CAGR and reach US$10.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Deep Brain Stimulation segment is readjusted to a revised 12% CAGR for the next 8-year period.
The U.S. Market is Estimated at $2.6 Billion, While China is Forecast to Grow at 11.1% CAGR
The Neuroprosthetics market in the U.S. is estimated at US$2.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2030 trailing a CAGR of 11.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.2% and 10.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.Select Competitors (Total 44 Featured) -
- Abbott Laboratories
- Boston Scientific Corporation
- Cochlear Ltd.
- LivaNova PLC
- Medtronic PLC
- NDI Medical
- NeuroPace, Inc.
- Nevro Corp.
- Retina Implant AG
- Second Sight Medical Products, Inc.
- Sonova Holding AG
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Neuroprosthetics - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
- An Introduction to Neuroprosthetics
- Types of Neuroprosthetics
- Cochlear Implants
- Bionic Eye/Retinal Implants
- Motor Prosthetics
- Cognitive Prosthetics
3. MARKET TRENDS & DRIVERS
- Neuroprosthetics Space Continues to Evolve
- Rise in Neurological Disorders and Nerve Injuries Drives Neuroprosthetics Market
- Growing Cases of Hearing Losses to Fuel Market Growth
- Increasing Prevalence of Diabetes Presents Opportunity for Neuroprosthetics Market
- Smart Neuroprosthetics Evolves to Boost Market Growth
- Artificial Intelligence’s Growing Role in Neuroprosthetic Devices
- Additive Micromanufacturing and Neuroprosthetics
- 3D Bioprinter Enables Printing of Customized Neuroprostheses
- Memristors Hold Potential to Develop Accurate and Affordable Neuroprosthetics
- Multi-functional Neuroprosthetic Enable Restoration of Motor Function in Spinal Cord Injury
- Innovations, Research Developments in Neuroprosthetics to Boost Prospects
- Challenges Facing Neuroprosthetics market
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Neuroprosthetics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- Table 2: World Recent Past, Current & Future Analysis for Neuroprosthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 3: World 8-Year Perspective for Neuroprosthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 5: World 8-Year Perspective for Spinal Cord Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 6: World Recent Past, Current & Future Analysis for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 7: World 8-Year Perspective for Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 8: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 9: World 8-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 11: World 8-Year Perspective for Sacral Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 12: World Recent Past, Current & Future Analysis for Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 13: World 8-Year Perspective for Transcranial Magnetic Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 14: World Recent Past, Current & Future Analysis for Motor Neuron Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 15: World 8-Year Perspective for Motor Neuron Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Cognitive Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 17: World 8-Year Perspective for Cognitive Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 18: World Recent Past, Current & Future Analysis for Physiological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 19: World 8-Year Perspective for Physiological Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
UNITED STATES
- Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 20: USA Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 21: USA 8-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2023 & 2030
- Table 22: USA Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 23: USA 8-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2023 & 2030
CANADA
- Table 24: Canada Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 25: Canada 8-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2023 & 2030
- Table 26: Canada Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 27: Canada 8-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2023 & 2030
JAPAN
- Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 28: Japan Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 29: Japan 8-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2023 & 2030
- Table 30: Japan Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 31: Japan 8-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2023 & 2030
CHINA
- Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 32: China Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 33: China 8-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2023 & 2030
- Table 34: China Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 35: China 8-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2023 & 2030
EUROPE
- Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 36: Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 37: Europe 8-Year Perspective for Neuroprosthetics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
- Table 38: Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 39: Europe 8-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2023 & 2030
- Table 40: Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 41: Europe 8-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2023 & 2030
FRANCE
- Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 42: France Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 43: France 8-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2023 & 2030
- Table 44: France Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 45: France 8-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2023 & 2030
GERMANY
- Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 46: Germany Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 47: Germany 8-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2023 & 2030
- Table 48: Germany Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 49: Germany 8-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2023 & 2030
ITALY
- Table 50: Italy Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 51: Italy 8-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2023 & 2030
- Table 52: Italy Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 53: Italy 8-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2023 & 2030
UNITED KINGDOM
- Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 54: UK Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 55: UK 8-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2023 & 2030
- Table 56: UK Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 57: UK 8-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2023 & 2030
REST OF EUROPE
- Table 58: Rest of Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 59: Rest of Europe 8-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2023 & 2030
- Table 60: Rest of Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 61: Rest of Europe 8-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2023 & 2030
ASIA-PACIFIC
- Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 62: Asia-Pacific Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 63: Asia-Pacific 8-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2023 & 2030
- Table 64: Asia-Pacific Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 65: Asia-Pacific 8-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2023 & 2030
REST OF WORLD
- Table 66: Rest of World Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 67: Rest of World 8-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2023 & 2030
- Table 68: Rest of World Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 69: Rest of World 8-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2023 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Boston Scientific Corporation
- Cochlear Ltd.
- LivaNova PLC
- Medtronic PLC
- NDI Medical
- NeuroPace, Inc.
- Nevro Corp.
- Retina Implant AG
- Second Sight Medical Products, Inc.
- Sonova Holding AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 193 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 9 Billion |
| Forecasted Market Value ( USD | $ 22.5 Billion |
| Compound Annual Growth Rate | 12.1% |
| Regions Covered | Global |
